In an interview with Targeted Oncology, Mark R. Litzow, MD, discussed the incorporation of Immunotherapy into upfront acute ...

A significant survival improvement finding for adults with newly diagnosed BCR::ABL1-negative B-cell precursor acute lymphoblastic leukemia appears in the New England Journal of Medicine.

At a median follow-up of 18 months, the OS rate was 95% and the DFS rate was 88%. 14 Long-term follow-up at a median of 53 ...

Survival depends on different factors. So no one can tell you exactly how long you will live. Doctors usually work out the outlook for a certain disease by looking at large groups of people. Because ...

New therapies like this one, it's called blinatumomab, are proving effective but there are still too many childhood cancers ...

PhD Defense: Towards optimal therapy intensity in pediatric acute lymphoblastic leukemia; The right dose for the right patient ...

Alec O'Connor, a twin from Fort Worth, Texas, was diagnosed with acute lymphoblastic leukemia, a rare and aggressive blood ...

Blincyto (blinatumomab) is a brand-name drug prescribed for certain types of acute lymphoblastic leukemia (ALL) in adults and most children. The dosage can vary depending on whether ALL is in ...

Latest Derby County news from Derbyshire Live brings you news of Cashin's bid to help his friend who is in hospital with rare ...

When 15-year-old Desert Edge High School volleyball player Allyson Bogoski was diagnosed with Acute Lymphoblastic Leukemia ...